or
forgot password

    • cancer clinical trials in lexington, KY

    • S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Colorectal Cancer
    Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Non-Hodgkin's Lymphoma, Lymphoma, B-cell, Lymphoma, Low-grade
    An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
    University of Kentucky Medical Center
    Lexington, Kentucky 40536-0093
    Breast Neoplasms, Breast Cancer, Metastasis
    S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
    Veterans Affairs Medical Center - Lexington

    Trial Locations
    Veterans Affairs Medical Center - Lexington
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Leukemia
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Cancer Center at Lexington Clinic
    Lexington, Kentucky 40504
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Albert B. Chandler Medical Center, University of Kentucky

    Trial Locations
    Albert B. Chandler Medical Center, University of Kentucky
    Veterans Affairs Medical Center - Lexington
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Albert B. Chandler Medical Center, University of Kentucky
    Lexington, Kentucky 40536-0084
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
    Veterans Affairs Medical Center - Lexington

    Trial Locations
    Veterans Affairs Medical Center - Lexington
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Bladder Cancer, Urethral Cancer
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lung Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Pancreatic Cancer
    S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
    Albert B. Chandler Medical Center, University of Kentucky

    Trial Locations
    Albert B. Chandler Medical Center, University of Kentucky
    Veterans Affairs Medical Center - Lexington
    Cervical Cancer
    Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Lung Cancer
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Metastatic Cancer, Sarcoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
    Veterans Affairs Medical Center - Lexington

    Trial Locations
    Veterans Affairs Medical Center - Lexington
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lung Cancer
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Lymphoma
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Pancreatic Cancer
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Markey Cancer Center at University of Kentucky Chandler Medical Center

    Trial Locations
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Central Baptist Hospital
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Lexington

    Trial Locations
    Veterans Affairs Medical Center - Lexington
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Colorectal Cancer
    Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
    University of Kentucky Medical Center
    Lexington, Kentucky 40536-0093
    Glioblastoma Multiforme
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Brain Tumor, Central Nervous System Tumor
    Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Endometrial Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Esophageal Cancer
    A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
    Lexington, Kentucky
    Non Small Cell Lung Carcinoma
    Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Lymphoma
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Esophageal Cancer
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Recurrent Childhood Acute Lymphoblastic Leukemia
    Trial of rPA-102 Vaccine in Healthy Adult Volunteers
    University of Kentucky, Markey Cancer Center
    Lexington, Kentucky 40536-0093
    Anthrax
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Brain and Central Nervous System Tumors
    ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
    University of Kentucky Medical Center

    Trial Locations
    University of Kentucky Medical Center
    Unversity of Kentucky Medical Center - Markey Center
    Pancreatic Cancer, Adenocarcinoma
    Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
    University of Kentucky College of Medicine, Markey Cancer Center
    Lexington, Kentucky 40536-0093
    Myelodysplastic Syndrome, Iron Overload
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Sarcoma
    Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Lung Cancer
    Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
    Markey Cancer Center, University of Kentucky
    Lexington, Kentucky 40536
    Small Cell Lung Cancer
    Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Papillomavirus Infection
    Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
    University of Kentucky

    Trial Locations
    University of Kentucky
    University of Kentucky - C201 Clinic
    Leukemia, Myeloid, Chronic Phase
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1892
    Lexington, Kentucky 40536
    Crohn's Disease